Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

It seems that trials already started. This could be a game changer.

  • toiletobserver@lemmy.world
    5·
    10 months ago

    Only ten more years until a cure for type 1 diabetes… no offense internet, but I’ve been hearing this for decades. I’ll gladly eat my hat when I’m wrong.

  • adj16@lemmy.worldEnglish
    51·
    10 months ago

    Sensationalist headline for what is truthfully a promising but as of yet poorly-tested idea. I very much look forward to seeing how this concept progresses!

  • Ashyr@sh.itjust.works
    31·
    10 months ago

    No reason this couldn’t work for Celiacs, I’d reckon, assuming it works at all. It would be nice to eat bread again.

  • I'm back on my BS 🤪@lemmy.worldEnglish
    2·
    10 months ago

    I would cry if this became a reality for ulcerative colitis. No more daily blood, no more weekly injections in the abs, no more quarterly GI visits, no more semi-annual colonoscopies, no more explaining it to people, no more constant fear of a flare or shitting myself around the corner.

  • russjr08@outpost.zeuslink.netEnglish
    21·
    10 months ago

    Now this is definitely quite a concept! It’s one of those ideas that always seemed like one that we should strive to achieve.

    I’ve gone ahead and used Kagi’s “summarizer” to get a condensed version of this article, for those who might not have the time to go through the full article at the time of reading:

    Researchers at the University of Chicago have developed a new type of vaccine that can potentially reverse autoimmune diseases like multiple sclerosis, type 1 diabetes and Crohn’s disease. Unlike traditional vaccines, this “inverse vaccine” works by erasing the immune system’s memory of certain molecules to stop the autoimmune response.

    In animal tests, the vaccine eliminated the autoimmune response associated with multiple sclerosis. It works by tagging molecules with a sugar that signals the immune system not to attack, allowing nerves and tissues to function normally again. If successful in humans, this new approach could offer more targeted treatment of autoimmune diseases with fewer side effects than current immunosuppressive drugs.

    Clinical trials are underway and researchers hope this innovative “inverse vaccine” concept can eventually help many patients suffering from difficult to treat conditions.